We narrowed to 1,035 results for: AAV

1. AAV phSyn1(S)-tdTomato-WPRE (AAV5)

   Viral Prep

   #51506-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from AAV phSyn1(S)-tdTomato-WPRE (#51506). In addition to the viral particles, you will also receive purified AAV phSyn1(S)-tdTomato-WPRE plasmid DNA. hSyn-driven tdTomato expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Hongkui Zeng

   Article

   Oh et al Nature. 2014 Apr 10;508(7495):207-14. do

   Promoter

   phSyn1

   Tags

   tdTomato

   Available Since

   Nov. 29, 2021

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-CaMKIIa-hM3D(Gq)-mCherry (AAV1)

   Viral Prep

   #50476-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-CaMKIIa-hM3D(Gq)-mCherry (#50476). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hM3D(Gq)-mCherry plasmid DNA. CaMKIIa-driven hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Bryan Roth

   Promoter

   CaMKII

   Available Since

   Jan. 8, 2025

   Availability

   Academic Institutions and Nonprofits only

3. pAAV_hSyn-PdCO-mScarlet-WPRE (AAV5)

   Viral Prep

   #198510-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV_hSyn-PdCO-mScarlet-WPRE (#198510). In addition to the viral particles, you will also receive purified pAAV_hSyn-PdCO-mScarlet-WPRE plasmid DNA. Syn-driven expression of optimized PdCO in frame with mScarlet. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Ofer Yizhar

   Article

   Wietek et al Nat Methods. 2024 May 29. doi: 10.1038/s

   Promoter

   Syn

   Tags

   mScarlet

   Available Since

   Sept. 27, 2024

   Availability

   Academic Institutions and Nonprofits only

4. pAAV-hSyn-GRAB-rDA3m (AAV1)

   Viral Prep

   #208702-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-hSyn-GRAB-rDA3m (#208702). In addition to the viral particles, you will also receive purified pAAV-hSyn-GRAB-rDA3m plasmid DNA. Synapsin-driven expression of genetically-encoded fluorescent dopamine (DA) sensor GRAB_rDA3m. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Yulong Li

   Article

   Zhuo et al Nat Methods. 2023 Nov 30. doi: 10.1038/s

   Promoter

   Syn

   Available Since

   Aug. 7, 2025

   Availability

   Academic Institutions and Nonprofits only

5. pAAV-CAG-GFP (AAV1 trial size)

   Viral Prep

   #37825-AAV1.T

   Purpose

   Ready-to-use AAV1 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   GFP

   Available Since

   May 29, 2019

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-flex-taCasp3-TEVp (AAV1)

   Viral Prep

   #45580-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-flex-taCasp3-TEVp (#45580). In addition to the viral particles, you will also receive purified pAAV-flex-taCasp3-TEVp plasmid DNA. EF1a-driven, Cre-dependent, bicicstronic expression of designer pro-taCasp3 and TEVp. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jim Wells, Nirao Shah

   Article

   Yang et al Cell. 2013 May 9;153(4):896-909. doi: 10

   Promoter

   EF1a

   Available Since

   Dec. 3, 2020

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-Ef1a-fDIO-tdTomato (AAV1)

   Viral Prep

   #128434-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-Ef1a-fDIO-tdTomato (#128434). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO-tdTomato plasmid DNA. EF1a-driven, Flp-dependent expression of tdTomato. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Patricia Jensen

   Article

   Sciolino et al Sci Adv. 2022 Aug 19;8(33):eabn9134. doi

   Promoter

   EF1a

   Tags

   tdTomato (Flp-dependent)

   Available Since

   March 12, 2021

   Availability

   Academic Institutions and Nonprofits only

8. pAAV-Syn-ChrimsonR-tdT (AAV5)

   Viral Prep

   #59171-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV-Syn-ChrimsonR-tdT (#59171). In addition to the viral particles, you will also receive purified pAAV-Syn-ChrimsonR-tdT plasmid DNA. Syn-driven ChrimsonR-tdTomato expression for optogenetic neural activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:

   Promoter

   Syn

   Tags

   tdTomato

   Available Since

   Feb. 7, 2018

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-CAG-GFP (AAV5 trial size)

   Viral Prep

   #37825-AAV5.T

   Purpose

   Ready-to-use AAV5 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   GFP

   Available Since

   May 29, 2019

   Availability

   Academic Institutions and Nonprofits only

10. pAAV-mDlx-GCaMP6f-Fishell-2 (AAV1)

    Viral Prep

    #83899-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-mDlx-GCaMP6f-Fishell-2 (#83899). In addition to the viral particles, you will also receive purified pAAV-mDlx-GCaMP6f-Fishell-2 plasmid DNA. mDlx-driven expression of GCaMP6f. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Gordon Fishell

    Article

    Dimidschstein et al Nat Neurosci. 2016 Oct 31. doi: 10.1038/

    Promoter

    mDlx

    Available Since

    Nov. 13, 2020

    Availability

    Academic Institutions and Nonprofits only

11. AAV-CAG-jGCaMP8f-WPRE (AAV9)

    Viral Prep

    #179254-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from AAV-CAG-jGCaMP8f-WPRE (#179254). In addition to the viral particles, you will also receive purified AAV-CAG-jGCaMP8f-WPRE plasmid DNA. CAG-driven expression of calcium sensor GCaMP8f. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Loren Looger

    Promoter

    CAG

    Available Since

    May 19, 2023

    Availability

    Academic Institutions and Nonprofits only

12. pAAV-CAG-GFP (AAV9 trial size)

    Viral Prep

    #37825-AAV9.T

    Purpose

    Ready-to-use AAV9 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Edward Boyden

    Promoter

    CAG

    Tags

    GFP

    Available Since

    May 29, 2019

    Availability

    Academic Institutions and Nonprofits only

13. AAV-EF1a-jGCaMP8m-WPRE (AAV9)

    Viral Prep

    #176757-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from AAV-EF1a-jGCaMP8m-WPRE (#176757). In addition to the viral particles, you will also receive purified AAV-EF1a-jGCaMP8m-WPRE plasmid DNA. EF1a-driven expression of calcium sensor GCaMP8m. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Loren Looger

    Promoter

    EF1a

    Available Since

    Feb. 24, 2023

    Availability

    Academic Institutions and Nonprofits only

14. pAAV_hSyn1-SIO-stGtACR2-FusionRed (AAV5)

    Viral Prep

    #105677-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV_hSyn1-SIO-stGtACR2-FusionRed (#105677). In addition to the viral particles, you will also receive purified pAAV_hSyn1-SIO-stGtACR2-FusionRed plasmid DNA. Synapsin-driven, Cre-dependent, soma-targeted anion-conducting channelrhodopsin fused to FusionRed for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Ofer Yizhar

    Article

    Mahn et al Nat Commun. 2018 Oct 8;9(1):4125. doi: 1

    Promoter

    Syn

    Tags

    FusionRed (Cre-dependent)

    Available Since

    Oct. 21, 2024

    Availability

    Academic Institutions and Nonprofits only

15. pAAV-hSyn-hM3D(Gq)-mCherry (AAV5)

    Viral Prep

    #50474-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-hSyn-hM3D(Gq)-mCherry (#50474). In addition to the viral particles, you will also receive purified pAAV-hSyn-hM3D(Gq)-mCherry plasmid DNA. hSyn-driven hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    Syn

    Tags

    mCherry

    Available Since

    Dec. 21, 2016

    Availability

    Academic Institutions and Nonprofits only

16. pAAV-mDlx-GFP-Fishell-1 (AAV1)

    Viral Prep

    #83900-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-mDlx-GFP-Fishell-1 (#83900). In addition to the viral particles, you will also receive purified pAAV-mDlx-GFP-Fishell-1 plasmid DNA. mDlx-driven expression of GFP in GABA-ergic interneurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Gordon Fishell

    Article

    Dimidschstein et al Nat Neurosci. 2016 Oct 31. doi: 10.1038/

    Promoter

    mDlx

    Tags

    GFP

    Available Since

    Jan. 26, 2021

    Availability

    Academic Institutions and Nonprofits only

17. pAAV-CaMKIIa-hM4D(Gi)-mCherry (AAV9)

    Viral Prep

    #50477-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-CaMKIIa-hM4D(Gi)-mCherry (#50477). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hM4D(Gi)-mCherry plasmid DNA. CaMKIIa-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced neuronal silencing. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    CaMKII

    Tags

    mCherry

    Available Since

    Jan. 26, 2021

    Availability

    Academic Institutions and Nonprofits only

18. AAV-mDlx-jGCaMP8m-WPRE (AAV9)

    Viral Prep

    #176754-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from AAV-mDlx-jGCaMP8m-WPRE (#176754). In addition to the viral particles, you will also receive purified AAV-mDlx-jGCaMP8m-WPRE plasmid DNA. mDlx enhancer-driven expression of calcium sensor GCaMP8m in GABA-ergic interneurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Loren Looger

    Promoter

    mDlx

    Available Since

    Feb. 24, 2023

    Availability

    Academic Institutions and Nonprofits only

19. AAV-CAG-jGCaMP8f-WPRE (AAV1)

    Viral Prep

    #179254-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from AAV-CAG-jGCaMP8f-WPRE (#179254). In addition to the viral particles, you will also receive purified AAV-CAG-jGCaMP8f-WPRE plasmid DNA. CAG-driven expression of calcium sensor GCaMP8f. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Loren Looger

    Promoter

    CAG

    Available Since

    May 18, 2023

    Availability

    Academic Institutions and Nonprofits only

20. pAAV-hSynapsin1-axon-GCaMP6f (AAV1)

    Viral Prep

    #112000-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-hSynapsin1-axon-GCaMP6f (#112000). In addition to the viral particles, you will also receive purified pAAV-hSynapsin1-axon-GCaMP6f plasmid DNA. Synapsin-driven, axon-targeted GCaMP6f calcium sensor. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Lin Tian

    Article

    Broussard et al Nat Neurosci. 2018 Sep;21(9):1272-1280.

    Promoter

    Syn

    Available Since

    March 12, 2021

    Availability

    Academic Institutions and Nonprofits only